As a recognized leader in the contract research organization (CRO) industry for conducting complex infectious disease trials, PharPoint Research has contributed expert services critical to the approval of many important infectious disease drugs. PharPoint Research has participated in 247 infectious disease studies in every phase and many indications, including respiratory syncytial virus (RSV), ebola virus, hepatitis-B infection, influenza, HIV, and hepatitis-C infection. Our significant infectious disease therapeutic experience encompasses 26 infectious disease indications. We have provided biostatistics and data management services for dozens of these infectious disease trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for infectious disease studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.